Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,000
Closed -$307K 154
2026
Q1
$307K Hold
3,000
﹤0.01% 119
2025
Q4
$302K Hold
3,000
﹤0.01% 110
2025
Q3
$259K Sell
3,000
-147,000
-98% -$11.6M ﹤0.01% 111
2025
Q2
$11.4M Hold
150,000
0.05% 80
2025
Q1
$10.6M Hold
150,000
0.05% 73
2024
Q4
$11.7M Hold
150,000
0.05% 82
2024
Q3
$15.3M Buy
+150,000
New +$12.4M 0.07% 84

Other funds holding NUVL

Thomas Steyer's NUVL Position: Q2 2026 in Review

Thomas Steyer sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 3,000 shares — an estimated $307K sold.

Thomas Steyer first reported a position in NUVL in Q3 2024 and held it in 7 quarters. The position peaked at $15.3M in Q3 2024. 287 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Thomas Steyer reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
  • Thomas Steyer sold 3,000 Nuvalent shares in Q2 2026, an estimated $307K.
  • Thomas Steyer first reported a position in Nuvalent in Q3 2024 and held it in 7 quarters.
  • Thomas Steyer's Nuvalent position peaked at $15.3M in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.